330729P

C15 Glucosyl(β) Ceramide-d7 (d18:1-D7/15:0)

Avanti Polar Lipids

• 同義詞: D-glucosyl-β-1,1′-N-pentadecanoyl-D-erythro-sphingosine-d7
• 經驗公式（希爾表示法）: C₃₉H₆₈D₇NO₈
• CAS號碼: 2315262-18-9
• 分子量：: 693.06
• 分類程式碼代碼: 12352211

屬性

• 化驗: 99% (TLC)
• 形狀: powder
• 包裝: pkg of 1 × 1 mg (330729P-1MG)
• 製造商／商標名: Avanti Polar Lipids
• 運輸包裝: dry ice
• 儲存溫度: −20°C
• SMILES 字串: [H][C@@](/C=C/CCCCCCCCCCC([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])(O)[C@@]([H])(NC(CCCCCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@@H]([C@H]1CO)O

描述

一般說明

C15 Glucosyl(β) Ceramide-d7 (d18:1-D7/15:0) is a deuterated derivative of C15 Glucosyl(β) Ceramide. β-Glucosyl ceramide (β-GlcCer) is an intracellular metabolite. It is the first intermediate in the synthesis of glycosphigolipids. β-GlcCer is an endogenous ligand of Mincle.

生化／生理作用

β-Glucosyl ceramide (β-GlcCer) exhibits immunostimulatory activity. Accumulation of β-GlcCer is associated with Gaucher disease.

包裝

5 mL Amber Glass Screw Cap Vial

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

安全資訊

• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable